Exercise Behavior, Functional Capacity, and Survival in Adults With Malignant Recurrent Glioma
- 20 July 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (21), 2918-2923
- https://doi.org/10.1200/jco.2011.34.9852
Abstract
Purpose Identifying strong markers of prognosis are critical to optimize treatment and survival outcomes in patients with malignant recurrent glioma. We investigated the prognostic significance of exercise behavior and functional capacity in this population. Patients and Methods Using a prospective design, 243 patients with WHO grades 3 to 4 recurrent malignant glioma and Karnofsky performance status (KPS) ≥ 70 completed a self-administered questionnaire that assessed exercise behavior and performed a 6-minute walk test (6MWT) to assess functional capacity. Cox proportional models were used to estimate the risk of all-cause mortality according to 6MWT distance (6MWD; < 390 meters, 390-489 meters, > 489 meters) and exercise behavior (metabolic equivalent [MET] –h/wk) adjusted for KPS and other important clinical factors. Results Median follow-up was 27.43 months. During this period, 149 deaths were recorded (61% of the total sample). Exercise behavior was an independent predictor of survival (P = .0081). M...Keywords
This publication has 28 references indexed in Scilit:
- American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer SurvivorsMedicine & Science in Sports & Exercise, 2010
- Changes in Functional Performance Measures in Adults Undergoing Chemoradiation for Primary Malignant Glioma: A Feasibility StudyThe Oncologist, 2010
- Joint NCCTG and NABTC prognostic factors analysis for high-grade recurrent gliomaNeuro-Oncology, 2009
- Influence of Pre- and Postdiagnosis Physical Activity on Mortality in Breast Cancer Survivors: The Health, Eating, Activity, and Lifestyle StudyJournal of Clinical Oncology, 2008
- Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendationsThe Lancet Oncology, 2008
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomasNeuro-Oncology, 2008
- Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Physical Activity and Survival After Colorectal Cancer DiagnosisJournal of Clinical Oncology, 2006
- Reference Values for a Multiple Repetition 6-Minute Walk Test in Healthy Adults Older Than 20 YearsJournal of Cardiopulmonary Rehabilitation, 2001
- Cognitive Function as a Predictor of Survival in Patients With Recurrent Malignant GliomaJournal of Clinical Oncology, 2000